ABBV vs UNH: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$304.33
+41.3% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
UNH has more upside to fair value
(+41.3%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
UNH |
| Current Price |
$208.05 |
$304.33 |
| Fair Value Estimate |
$217.50 |
$430.00 |
| Upside to Fair Value |
+4.5%
|
+41.3%
|
| Market Cap |
$367.9B |
$276.2B |
| Forward P/E |
14.9x
|
15.1x
|
| EV / EBITDA |
16.7x
|
14.3x
|
| Price / Sales |
6.1x
|
0.6x
|
| Price / FCF |
20.9x
|
17.2x
|
| Revenue Growth YoY |
+8.6%
|
+11.8%
|
| Gross Margin |
83.7%
|
18.5%
|
| Operating Margin |
34.7%
|
4.2%
|
| Return on Equity |
-129.24%
|
12.7%
|
| Dividend Yield |
3.2% |
2.9% |
| FCF Yield |
4.78%
|
5.82%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
UnitedHealth Group is the world's largest diversified healthcare company, combining the dominant US health insurer UnitedHealthcare with the high-margin Optum services platform spanning care delivery, pharmacy benefits, and data analytics. The stock has fallen roughly 49% from its 2024 peak of $596, driven by elevated medical costs, DOJ antitrust scrutiny, CEO transitions (Brian Thompson's murder…
Accumulation Zones
| Metric |
ABBV |
UNH |
| Zone Low |
$163.13 |
$280.00 |
| Zone High |
$184.88 |
$340.00 |
| In Buy Zone? |
No
|
Yes
|